Results from the Phase III MYR301 trial show that 36% of patients who achieved undetectable hepatitis delta virus levels when ...

The Cambridgeshire man's mum had both Hepatitis B and C and her health suffered for many years as a result of it.

Let us delve into some of the TLR agonists in the clinic and why the careful selection of these drugs is crucial.

Record HEPLISAV-B® first quarter net product revenue of $65 million, representing 36% year-over-year growth Top-line results in Part 1 of Phase 1/2 shingles vaccine ...

Vaccine programs almost eradicated measles, but cases are rising again in every part of the world. What's behind the ...

Immunocore reports first quarter financial results and provides a business update KIMMTRAK® (tebentafusp-tebn) net revenues of $93.9 million in Q1 2025, growing by 33% year-over-year ...

Commonwealth Court judge finds that the county health department cannot override a municipal health department that existed ...

AbolerIS Pharma ("AbolerIS"), a clinical-stage biopharmaceutical company committed to improving the lives of people suffering from autoimmune and inflammatory diseases, announced today that the first ...

Thankful­ly, assisted reproductive technology have made the world. Diabetes that is not well controlled causes the baby’s blood sugar to be high. The baby is “overfed” and grows extra-large. Besides ...

IT has been announced that opt-out testing for blood-borne viruses will soon be rolled out in Edinburgh and Glasgow.

White patients had an increased burden of advanced liver fibrosis vs Black patients, despite comparable levels of inflammation.

Although US mortality rates from concurrent HIV and viral hepatitis infection have declined since the late 1990s, gender disparities persist.